VITALHUB CORP (VHI.CA) Stock Fundamental Analysis
Canada - Toronto Stock Exchange - TSX:VHI - CA92847V5018 - Common Stock
9.1 CAD
+0.05 (+0.55%)
We assign a fundamental rating of 6 out of 10 to VHI. VHI was compared to 9 industry peers in the Health Care Technology industry. Both the health and profitability get an excellent rating, making VHI a very profitable company, without any liquidiy or solvency issues. VHI is not priced too expensively while it is growing strongly. Keep and eye on this one! With these ratings, VHI could be worth investigating further for growth and quality investing!.
1. Profitability
1.1 Basic Checks
In the past year VHI was profitable.
In the past year VHI had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: VHI reported negative net income in multiple years.
Of the past 5 years VHI 4 years had a positive operating cash flow.
1.2 Ratios
VHI has a Return On Assets of 0.76%. This is amongst the best in the industry. VHI outperforms 88.89% of its industry peers.
VHI has a Return On Equity of 1.08%. This is amongst the best in the industry. VHI outperforms 88.89% of its industry peers.
VHI's Return On Invested Capital of 2.86% is amongst the best of the industry. VHI outperforms 100.00% of its industry peers.
VHI had an Average Return On Invested Capital over the past 3 years of 3.96%. This is in line with the industry average of 2.16%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.76% | ||
| ROE | 1.08% | ||
| ROIC | 2.86% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
1.3 Margins
VHI has a better Profit Margin (2.88%) than 100.00% of its industry peers.
VHI has a Operating Margin of 12.47%. This is amongst the best in the industry. VHI outperforms 100.00% of its industry peers.
VHI's Operating Margin has improved in the last couple of years.
With an excellent Gross Margin value of 80.92%, VHI belongs to the best of the industry, outperforming 88.89% of the companies in the same industry.
In the last couple of years the Gross Margin of VHI has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.47% | ||
| PM (TTM) | 2.88% | ||
| GM | 80.92% |
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), VHI is destroying value.
Compared to 1 year ago, VHI has more shares outstanding
Compared to 5 years ago, VHI has more shares outstanding
VHI has a better debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 3.83 indicates that VHI is not in any danger for bankruptcy at the moment.
VHI has a Altman-Z score (3.83) which is in line with its industry peers.
VHI has a debt to FCF ratio of 0.13. This is a very positive value and a sign of high solvency as it would only need 0.13 years to pay back of all of its debts.
VHI's Debt to FCF ratio of 0.13 is amongst the best of the industry. VHI outperforms 100.00% of its industry peers.
VHI has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
VHI has a better Debt to Equity ratio (0.00) than 88.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.13 | ||
| Altman-Z | 3.83 |
ROIC/WACC0.33
WACC8.67%
2.3 Liquidity
VHI has a Current Ratio of 1.94. This is a normal value and indicates that VHI is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of VHI (1.94) is better than 77.78% of its industry peers.
VHI has a Quick Ratio of 1.94. This is a normal value and indicates that VHI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.94, VHI is in the better half of the industry, outperforming 77.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.94 |
3. Growth
3.1 Past
The earnings per share for VHI have decreased strongly by -14.29% in the last year.
The Revenue has grown by 59.34% in the past year. This is a very strong growth!
The Revenue has been growing by 46.32% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-14.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
Revenue 1Y (TTM)59.34%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%94.1%
3.2 Future
VHI is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 70.74% yearly.
Based on estimates for the next years, VHI will show a very strong growth in Revenue. The Revenue will grow by 27.33% on average per year.
EPS Next Y-6.21%
EPS Next 2Y86.09%
EPS Next 3Y70.74%
EPS Next 5YN/A
Revenue Next Year60.05%
Revenue Next 2Y38.57%
Revenue Next 3Y27.33%
Revenue Next 5YN/A
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 151.67, which means the current valuation is very expensive for VHI.
VHI's Price/Earnings ratio is rather cheap when compared to the industry. VHI is cheaper than 100.00% of the companies in the same industry.
VHI is valuated expensively when we compare the Price/Earnings ratio to 27.25, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 37.54, VHI can be considered very expensive at the moment.
VHI's Price/Forward Earnings ratio is rather cheap when compared to the industry. VHI is cheaper than 88.89% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.98, VHI is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 151.67 | ||
| Fwd PE | 37.54 |
4.2 Price Multiples
100.00% of the companies in the same industry are more expensive than VHI, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, VHI is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 47.14 | ||
| EV/EBITDA | 20.75 |
4.3 Compensation for Growth
The decent profitability rating of VHI may justify a higher PE ratio.
A more expensive valuation may be justified as VHI's earnings are expected to grow with 70.74% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y86.09%
EPS Next 3Y70.74%
5. Dividend
5.1 Amount
VHI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
TSX:VHI (1/12/2026, 7:00:00 PM)
9.1
+0.05 (+0.55%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners40.16%
Inst Owner ChangeN/A
Ins Owners11.45%
Ins Owner ChangeN/A
Market Cap574.39M
Revenue(TTM)98.17M
Net Income(TTM)2.83M
Analysts81.33
Price Target15.51 (70.44%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-78.71%
Min EPS beat(2)-129.12%
Max EPS beat(2)-28.31%
EPS beat(4)0
Avg EPS beat(4)-61.43%
Min EPS beat(4)-129.12%
Max EPS beat(4)-28.31%
EPS beat(8)0
Avg EPS beat(8)-58.34%
EPS beat(12)1
Avg EPS beat(12)-46.79%
EPS beat(16)2
Avg EPS beat(16)-54.73%
Revenue beat(2)2
Avg Revenue beat(2)9.95%
Min Revenue beat(2)7.24%
Max Revenue beat(2)12.66%
Revenue beat(4)4
Avg Revenue beat(4)6.3%
Min Revenue beat(4)0.61%
Max Revenue beat(4)12.66%
Revenue beat(8)6
Avg Revenue beat(8)4.15%
Revenue beat(12)10
Avg Revenue beat(12)4.05%
Revenue beat(16)12
Avg Revenue beat(16)4.16%
PT rev (1m)0%
PT rev (3m)-1.75%
EPS NQ rev (1m)-25%
EPS NQ rev (3m)-41.67%
EPS NY rev (1m)-4.1%
EPS NY rev (3m)-44.09%
Revenue NQ rev (1m)0.57%
Revenue NQ rev (3m)4.7%
Revenue NY rev (1m)0.42%
Revenue NY rev (3m)4.24%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 151.67 | ||
| Fwd PE | 37.54 | ||
| P/S | 5.85 | ||
| P/FCF | 47.14 | ||
| P/OCF | 44.46 | ||
| P/B | 2.19 | ||
| P/tB | 11.67 | ||
| EV/EBITDA | 20.75 |
EPS(TTM)0.06
EY0.66%
EPS(NY)0.24
Fwd EY2.66%
FCF(TTM)0.19
FCFY2.12%
OCF(TTM)0.2
OCFY2.25%
SpS1.56
BVpS4.15
TBVpS0.78
PEG (NY)N/A
PEG (5Y)N/A
Graham Number2.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.76% | ||
| ROE | 1.08% | ||
| ROCE | 4.19% | ||
| ROIC | 2.86% | ||
| ROICexc | 4.95% | ||
| ROICexgc | N/A | ||
| OM | 12.47% | ||
| PM (TTM) | 2.88% | ||
| GM | 80.92% | ||
| FCFM | 12.41% |
ROA(3y)2.14%
ROA(5y)0.07%
ROE(3y)3.08%
ROE(5y)0.28%
ROIC(3y)3.96%
ROIC(5y)N/A
ROICexc(3y)5.88%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.82%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y132.1%
ROICexc growth 5YN/A
OM growth 3Y125.53%
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.9%
GM growth 5Y2.08%
F-Score3
Asset Turnover0.27
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.13 | ||
| Debt/EBITDA | 0.05 | ||
| Cap/Depr | 7.67% | ||
| Cap/Sales | 0.75% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 59.17% | ||
| Profit Quality | 430.43% | ||
| Current Ratio | 1.94 | ||
| Quick Ratio | 1.94 | ||
| Altman-Z | 3.83 |
F-Score3
WACC8.67%
ROIC/WACC0.33
Cap/Depr(3y)9.42%
Cap/Depr(5y)8.61%
Cap/Sales(3y)0.86%
Cap/Sales(5y)0.89%
Profit Quality(3y)466.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-14.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-133.33%
EPS Next Y-6.21%
EPS Next 2Y86.09%
EPS Next 3Y70.74%
EPS Next 5YN/A
Revenue 1Y (TTM)59.34%
Revenue growth 3Y40.63%
Revenue growth 5Y46.32%
Sales Q2Q%94.1%
Revenue Next Year60.05%
Revenue Next 2Y38.57%
Revenue Next 3Y27.33%
Revenue Next 5YN/A
EBIT growth 1Y46.83%
EBIT growth 3Y217.15%
EBIT growth 5YN/A
EBIT Next Year76.68%
EBIT Next 3Y40.05%
EBIT Next 5YN/A
FCF growth 1Y-12.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-10.32%
OCF growth 3YN/A
OCF growth 5YN/A
VITALHUB CORP / VHI.CA FAQ
What is the fundamental rating for VHI stock?
ChartMill assigns a fundamental rating of 6 / 10 to VHI.CA.
What is the valuation status of VITALHUB CORP (VHI.CA) stock?
ChartMill assigns a valuation rating of 5 / 10 to VITALHUB CORP (VHI.CA). This can be considered as Fairly Valued.
Can you provide the profitability details for VITALHUB CORP?
VITALHUB CORP (VHI.CA) has a profitability rating of 7 / 10.
Can you provide the financial health for VHI stock?
The financial health rating of VITALHUB CORP (VHI.CA) is 7 / 10.